Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,886.00
(
0.06%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
94.84
(
4.59%
)
Bitcoin
75,814.41
(
-0.10%
)
News Focus
News Focus
Post# of 97241
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: $heff post# 93680

Tuesday, 04/19/2016 6:00:03 PM

Tuesday, April 19, 2016 6:00:03 PM

Post# of 97241
Sheff—Here’s an updated ‘cheat sheet’ for ABBV/ENTA’s global phase-3 program for ABT-493/ABT-530: #msg-122031014.

With ten phase-3 trials including 2,500 patients and trial sites in about 30 countries, no one can say that ABBV is not “all in” on this program! Regards, Dew

Disclosure: I am long ENTA.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today